We report here the first cases, to our knowledge, of pulmonary arterial hypertension induced by lorlatinib. It s the first time that a tyrosine kinase inhibitor for lung cancer is associated with pulmonary arteriel hypertension.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.lungcan.2018.03.023 | DOI Listing |
Publication Analysis
Top Keywords
pulmonary arterial
8
arterial hypertension
8
lorlatinib induced
4
induced pulmonary
4
hypertension report
4
report cases
4
cases knowledge
4
knowledge pulmonary
4
hypertension induced
4
induced lorlatinib
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!